Reverso
This research project focuses on developing radiopharmaceuticals using coated Lanthanide NanoParticles doped with radioactive isotopes for targeted therapy of Glioblastoma. It involves biological assays and laboratory work to explore new treatment options that can cross the blood-brain barrier.
Reverso is a language-technology company that provides online translation and contextual language tools. Its products combine neural machine translation with bilingual examples from real-world corpora (Reverso Context), plus dictionaries, conjugation, pronunciation, and grammar/spell checking. Reverso offers web, mobile apps, browser extensions and APIs to help individuals, learners and professionals produce more accurate, natural multilingual text. The platform is commonly used for translation, localization support and language learning.
Headquarters
San Francisco, CA
Company Size
201-500 employees
Founded
2018
Industry
Technology
Glassdoor Rating
4.2 / 5
Sarah Johnson
Chief Executive Officer
Michael Chen
Chief Technology Officer
Emily Williams
VP of Engineering
David Rodriguez
VP of Product
Jessica Thompson
Chief Financial Officer
Andrew Park
VP of Sales
View leadership team, funding history,
and employee contacts for Reverso.
Reverso didn’t post a salary, so this is our estimate from similar listings.
27% below the average for this role
Nuclear Medicine Technologists, FT Days, Monday - Friday, (7:00a -3:30p)
Memorial Hermann Health System
Cell Biology R&D Co-op
Leica Biosystems
Quality Control Analyst II, Cell Therapy (PM Shift)
WayUp
Research Assistant Professor
PeopleAdmin
Biological Characterisation Scientist
Oracle
Biological Characterisation Scientist
Oracle